Lecanemab

Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody medication used for the treatment of Alzheimer's disease. Lecanemab is an amyloid beta-directed antibody. It is given via... Wikipedia

• Type:  Whole antibody
• Source:  Humanized
• Target:  Amyloid beta
• Trade names:  Leqembi
• AHFS/Drugs.com:  Monograph
• data:  US DailyMed: Lecanemab
• Routes of, administration:  Intravenous
• Legal status:  US: ℞-only
• CAS Number:  1260393-98-3
• ATC code:  N06DX04 (WHO)
• DrugBank:  DB14580
• ChemSpider:  none
• UNII:  12PYH0FTU9
• KEGG:  D11678
• Synonyms:  BAN2401, lecanemab-irmb
• Data source:  DuckDuckGo